Chemomab Therapeutics Ltd. (CMMB) Financials
CMMB Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 10.2 million | 1.6 million |
| March 31, 2026 | 11.8 million | 1.1 million |
| Dec. 31, 2025 | 13.8 million | 1.5 million |
| Sept. 30, 2025 | 12.4 million | 1.1 million |
CMMB Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | ? | ? |
| March 31, 2026 | ? | ? |
| Dec. 31, 2025 | -11.2 million | ? |
| Sept. 30, 2025 | ? | ? |
CMMB Net Income
No data available :(
CMMB Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 6.7 million | - | - |
| March 31, 2026 | 8.0 million | - | - |
| Dec. 31, 2025 | 10.4 million | - | - |
| Sept. 30, 2025 | 10.1 million | - | - |
CMMB Shares Outstanding
CMMB Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | - | 1.2 million | 1.1 million | - |
| March 31, 2026 | - | 925000 | 925000 | - |
| Dec. 31, 2025 | 3026 | 1.1 million | 881000 | - |
| Sept. 30, 2025 | - | 960000 | 884000 | - |
CMMB Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | - |
| Dec. 31, 2025 | - | - |
| Sept. 30, 2025 | - | - |
CMMB
Price: $2.58
52 week price:
Earnings Per Share: -1.05 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 37000
Market Capitalization: 17.4 million